INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,449,275 | -17.9% | 267,213 | +5.9% | 0.01% | -12.5% |
| Q2 2023 | $10,290,833 | -21.2% | 252,350 | -28.0% | 0.01% | -20.0% |
| Q1 2023 | $13,056,098 | +12.9% | 350,495 | +5.7% | 0.01% | +11.1% |
| Q4 2022 | $11,565,476 | -22.9% | 331,484 | +23.6% | 0.01% | -30.8% |
| Q3 2022 | $15,004,000 | +36.6% | 268,123 | +26.4% | 0.01% | +44.4% |
| Q2 2022 | $10,980,000 | +105.3% | 212,122 | +188.2% | 0.01% | +125.0% |
| Q1 2022 | $5,348,000 | -39.3% | 73,598 | -1.3% | 0.00% | -33.3% |
| Q4 2021 | $8,816,000 | -8.3% | 74,563 | +4.0% | 0.01% | -14.3% |
| Q3 2021 | $9,619,000 | -3.5% | 71,699 | +16.4% | 0.01% | 0.0% |
| Q2 2021 | $9,972,000 | +1610.5% | 61,592 | +69.1% | 0.01% | +600.0% |
| Q2 2017 | $583,000 | – | 36,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |